The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study

• Michelle T. Long ,

  * E-mail: mtlong@bu.edu

  Affiliations Division of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, United States of America, National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts, United States of America

  ⨯
• Alison Pedley,

  Affiliations National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts, United States of America, Merck Research Laboratories, Kenilworth, New Jersey, United States of America

  ⨯
• Joseph M. Massaro,

  Affiliations National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts, United States of America, Department of Mathematics and Statistics, Boston University, Boston, Massachusetts, United States of America

  ⨯
• Udo Hoffmann,

  Affiliation Radiology Department, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Caroline S. Fox

  Affiliations National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts, United States of America, Division of Endocrinology, Hypertension, and Metabolism, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯